Mark Joseph Chicarelli

This inventor holds 47 USPTO granted patents and 12 published patent applications, plus 4 CIPO patents and 19 EPO patents, primarily in Kinase Inhibitors. Top assignees: Array Biopharma Inc., Mirati Therapeutics, Inc., Genentech, Inc.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Joseph Chicarelli. Retrieved from https://idiyas.com/inventor/mark-joseph-chicarelli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 47 (Patent Applications = 12)

% Patents Active = 72.3

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 19 (Patent Applications = 22)

Average Co-Inventor Count = 10.2

ph-index = 9

Forward Citations = 235(Granted Patents)

Location History:

Westminster, CO (US) (2013)
Longmont, CO (US) (2010 - 2024)
Boulder, CO (US) (2012 - 2024)

Company Filing History:

Mirati Therapeutics, Inc.

Cogent Biosciences, Inc.

patents

6. 2 out of 4,517

Eli Lilly and Company

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

KRas G12C

Serine/Threonine

Glucokinase Activators

Protein Tyrosine Phosphatase

RET Kinase

Pyrrolopyridines

4,6-Substituted-Pyrazolo

2-Aminopyridine

Thiadiazole Derivatives

FGFR Inhibition

PI3K Inhibitors

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747253 - KRas G12D inhibitors (2026-09-29),

2. 12686692 - KRas G12D inhibitors (2026-07-21),

3. 12630566 - KRas G12D inhibitors (2026-05-19),

4. 12351581 - Compounds for FGFR inhibition (2025-07-08),

5. 12281122 - PI3K inhibitors (2025-04-21),

6. 12187721 - Protein tyrosine phosphatase inhibitors (2025-01-07),

7. 11964989 - KRas G12D inhibitors (2024-04-23),

8. 11932633 - KRas G12C inhibitors (2024-03-19),

9. 11884664 - Protein tyrosine phosphatase inhibitors (2024-01-30),

10. 11634417 - Protein tyrosine phosphatase inhibitors (2023-04-25),

11. 11453683 - KRas G12D inhibitors (2022-09-27),

12. 11267812 - KRAS G12C inhibitors (2022-03-08),

13. 11028093 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors (2021-06-08),

14. 10730880 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors (2020-08-04),

15. 10689377 - KRas G12C inhibitors (2020-06-23),

Title: The Inventor Mark Joseph Chicarelli

Introduction: Mark Joseph Chicarelli is a talented inventor based in Boulder, CO. He is known for his innovative spirit and dedication to creating groundbreaking solutions.

Latest Patents: Mark Joseph Chicarelli holds several patents in various fields, including technology, healthcare, and sustainability. His recent patents focus on renewable energy solutions and smart home technologies.

Career Highlights: Throughout his career, Mark Joseph Chicarelli has worked with leading companies to bring his inventions to life. He has a proven track record of turning ideas into successful products that make a positive impact on society.

Collaborations: Mark Joseph Chicarelli has collaborated with top researchers, engineers, and designers to enhance the functionality and efficiency of his inventions. His collaborative approach has led to the development of cutting-edge technologies.

Conclusion: In conclusion, Mark Joseph Chicarelli is a visionary inventor who continues to push the boundaries of innovation. His passion for creating meaningful solutions underscores his commitment to making the world a better place through his inventions.

Profile summary based on public USPTO records.